Gallstones Seen with Roche Weight Drug Say FDA Staff

WASHINGTON, April 10 (Reuters) - A review of Roche AG's Xenical has prompted concerns about a possible link between the weight-loss drug and gallstones in patients of all ages, U.S. regulatory staff said in a memo released on Tuesday.

>>> Discuss This Story